We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+19.87%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
+$17.9M
Cap. Flow
+$6.34M
Cap. Flow %
5.37%
Top 10 Hldgs %
16.29%
Holding
285
New
33
Increased
176
Reduced
36
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 43.59%
2 Miscellaneous 16.64%
3 Technology 10.39%
4 Industrials 9.8%
5 Real Estate 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCAT icon
76
Red Cat Holdings
RCAT
$1.28B
$533K 0.45%
50,000
+5,000
+11% +$57.6K
AGIO icon
77
Agios Pharmaceuticals
AGIO
$1.98B
$526K 0.45%
14,173
+202
+1% +$6.13K
KDK
78
Kodiak AI
KDK
$766M
$508K 0.43%
100,000
+25,000
+33% +$187K
NAMS icon
79
NewAmsterdam Pharma
NAMS
$3.04B
$504K 0.43%
14,868
+212
+1% +$6.99K
KTOS icon
80
Kratos Defense & Security Solutions
KTOS
$8.98B
$499K 0.42%
10,000
+2,000
+25% +$121K
EMHY icon
81
iShares JPMorgan EM High Yield Bond ETF
EMHY
$643M
$497K 0.42%
12,231
+421
+4% +$17K
EMB icon
82
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$496K 0.42%
5,148
+217
+4% +$20.8K
PBP icon
83
Invesco S&P 500 BuyWrite ETF
PBP
$379M
$495K 0.42%
21,627
+558
+3% +$12.6K
CWB icon
84
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
$494K 0.42%
4,579
-514
-10% -$53.3K
BKLN icon
85
Invesco Senior Loan ETF
BKLN
$6.73B
$492K 0.42%
24,153
+401
+2% +$8.22K
VYM icon
86
Vanguard High Dividend Yield ETF
VYM
$82.8B
$491K 0.42%
3,106
+10
+0.3% +$1.56K
MBOT icon
87
Microbot Medical
MBOT
$96.7M
$488K 0.41%
250,000
+50,000
+25% +$102K
CYTK icon
88
Cytokinetics
CYTK
$10.1B
$485K 0.41%
5,697
+81
+1% +$5.82K
DWX icon
89
State Street SPDR S&P International Dividend ETF
DWX
$533M
$485K 0.41%
10,549
+688
+7% +$32K
RGTI icon
90
Rigetti Computing
RGTI
$5.07B
$483K 0.41%
+25,000
New +$483K
CLDX icon
91
Celldex Therapeutics
CLDX
$3.12B
$476K 0.4%
12,784
+170
+1% +$5.49K
GPK icon
92
Graphic Packaging
GPK
$3.09B
$476K 0.4%
45,000
-10,000
-18% -$102K
CAH icon
93
Cardinal Health
CAH
$57.5B
$468K 0.4%
1,970
+105
+6% +$21.8K
L icon
94
Loews
L
$22.3B
$454K 0.39%
4,014
+203
+5% +$22K
TRVI icon
95
Trevi Therapeutics
TRVI
$2.46B
$454K 0.38%
24,317
+347
+1% +$5.05K
REM icon
96
iShares Mortgage Real Estate ETF
REM
$540M
$446K 0.38%
20,231
+11,136
+122% +$246K
IVZ icon
97
Invesco
IVZ
$14.6B
$435K 0.37%
16,483
+4,564
+38% +$121K
MU icon
98
Micron Technology
MU
$1.15T
$429K 0.36%
372
+69
+23% +$51.7K
CSCO icon
99
Cisco
CSCO
$431B
$426K 0.36%
3,628
+210
+6% +$22K
ALNY icon
100
Alnylam Pharmaceuticals
ALNY
$35.6B
$418K 0.35%
1,390
+20
+1% +$6.03K

Similar funds

AlphaCentric Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, AlphaCentric Advisors held 285 positions worth $118M, up 18% from $100M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AlphaCentric Advisors deployed $6.34M of net new capital in Q2 2026, opening 33 new positions and adding to 176 existing holdings. Its largest new stake was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $1.41M trimmed.

  • AlphaCentric Advisors's largest Q2 2026 buy was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.
  • AlphaCentric Advisors added most to Synopsys in Q2 2026, an estimated $400K increase.
  • AlphaCentric Advisors's biggest Q2 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.41M.
  • AlphaCentric Advisors fully exited Whitestone REIT in Q2 2026, selling an estimated $460K.
  • AlphaCentric Advisors's ten largest holdings make up 16% of its $118M portfolio in Q2 2026.
  • AlphaCentric Advisors opened 33 new positions and closed 26 in Q2 2026.
  • AlphaCentric Advisors's portfolio value rose 18% quarter-over-quarter to $118M.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.